KR20210017108A - Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component - Google Patents
Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component Download PDFInfo
- Publication number
- KR20210017108A KR20210017108A KR1020190095822A KR20190095822A KR20210017108A KR 20210017108 A KR20210017108 A KR 20210017108A KR 1020190095822 A KR1020190095822 A KR 1020190095822A KR 20190095822 A KR20190095822 A KR 20190095822A KR 20210017108 A KR20210017108 A KR 20210017108A
- Authority
- KR
- South Korea
- Prior art keywords
- black rice
- fermented black
- rice extract
- composition
- fermented
- Prior art date
Links
- 241000371652 Curvularia clavata Species 0.000 title claims abstract description 78
- 239000000284 extract Substances 0.000 title claims abstract description 68
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 20
- 230000002087 whitening effect Effects 0.000 title claims abstract description 19
- 239000004480 active ingredient Substances 0.000 claims abstract description 22
- 239000002537 cosmetic Substances 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 48
- 235000013376 functional food Nutrition 0.000 claims description 17
- 230000036541 health Effects 0.000 claims description 16
- 208000021710 Hyperpigmentation disease Diseases 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 208000003351 Melanosis Diseases 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 206010008570 Chloasma Diseases 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 7
- 208000000069 hyperpigmentation Diseases 0.000 claims description 7
- 230000003810 hyperpigmentation Effects 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 241000122821 Aspergillus kawachii Species 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006188 syrup Substances 0.000 claims description 4
- 235000020357 syrup Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 201000004624 Dermatitis Diseases 0.000 claims description 3
- 206010014970 Ephelides Diseases 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 claims description 3
- 206010064127 Solar lentigo Diseases 0.000 claims description 3
- 206010052428 Wound Diseases 0.000 claims description 3
- 208000027418 Wounds and injury Diseases 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 208000031019 skin pigmentation disease Diseases 0.000 abstract description 2
- 229940124597 therapeutic agent Drugs 0.000 abstract description 2
- 102000003425 Tyrosinase Human genes 0.000 description 20
- 108060008724 Tyrosinase Proteins 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 20
- 229930003935 flavonoid Natural products 0.000 description 15
- 235000017173 flavonoids Nutrition 0.000 description 15
- 150000002215 flavonoids Chemical class 0.000 description 15
- 235000013824 polyphenols Nutrition 0.000 description 14
- -1 polyphenol compounds Chemical class 0.000 description 13
- 230000002292 Radical scavenging effect Effects 0.000 description 12
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 150000008442 polyphenolic compounds Chemical class 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 5
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 5
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 150000002989 phenols Chemical class 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960000271 arbutin Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- 235000012241 calcium silicate Nutrition 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000003061 melanogenesis Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VIYKYVYAKVNDPS-HKGPVOKGSA-N (2s)-2-azanyl-3-[3,4-bis(oxidanyl)phenyl]propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 VIYKYVYAKVNDPS-HKGPVOKGSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- JGDITNMASUZKPW-UHFFFAOYSA-K aluminium trichloride hexahydrate Chemical compound O.O.O.O.O.O.Cl[Al](Cl)Cl JGDITNMASUZKPW-UHFFFAOYSA-K 0.000 description 1
- 229940009861 aluminum chloride hexahydrate Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 항산화 활성이 증진된 발효 흑미 추출물을 유효성분으로 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening comprising a fermented black rice extract with enhanced antioxidant activity as an active ingredient.
사람의 피부색은 멜라닌, 카로틴 및 헤모글로빈의 양에 따라 결정되는데, 이 중 멜라닌에 의한 영향이 가장 크며, 피부의 두께와 반사도 및 혈류량 등에 의해서도 영향을 받는다. 피부색을 결정하는 가장 중요한 요소인 멜라닌 색소는 인체에 정상적으로 존재하는 아미노산의 일종인 티로신(tyrosine)이 표피의 기저층에 존재하는 멜라닌 세포의 내부에 함유되어 있는 효소인 티로시나아제(tyrosinase)에 의해 도파(dopa)로 전환되고, 계속되는 일련의 복잡한 산화과정을 통해 최종적으로 흑갈색의 중합체인 멜라닌이 생성되는 것이다. 티로시나아제는 미생물, 식물 및 동물 등 거의 모든 생물종에 분포되어 있으며, 활성 부위에 한 쌍의 구리 이온을 함유하고 있는 금속 함유 단백질로, 티로시나아제의 기능은 피부와 관련된 질병과 밀접한 관련성이 있어, 지금까지의 미백제에 관한 연구들은 주로 티로시나아제의 활성 저해제를 개발하는데 치중되어 왔다. 동물에서는 멜라닌 합성의 이상에 따라 백반증 또는 색소침착과 같은 비정상적인 멜라닌 착색을 일으키며, 이는 더 심할 경우 피부암을 일으키기도 한다.Human skin color is determined by the amount of melanin, carotene, and hemoglobin, of which melanin has the greatest effect, and is also affected by skin thickness, reflectivity, and blood flow. The melanin pigment, which is the most important factor in determining skin color, is guided by tyrosinase, an enzyme contained inside melanocytes, which is a kind of amino acid normally present in the human body. It is converted to (dopa), and finally, melanin, a dark brown polymer, is produced through a series of complex oxidation processes. Tyrosinase is a metal-containing protein that is distributed in almost all species such as microorganisms, plants, and animals, and contains a pair of copper ions in the active site.The function of tyrosinase is closely related to skin-related diseases. So far, studies on whitening agents have been mainly focused on developing inhibitors of tyrosinase activity. In animals, abnormal melanin synthesis causes abnormal melanin pigmentation, such as vitiligo or pigmentation, which can lead to skin cancer in more severe cases.
현재 알려져 있는 미백을 위한 방법들은 자외선 차단, 유전자 발현 억제, 효소작용 억제, 색소 환원 및 각질층 제거 등이 있다. 미백 기능을 나타내는 대표적 단일 물질로는 알부틴, 코지산, 아스코르브산 및 히드로퀴논 등이 사용되고 있으며, 현재 자연 친화적인 미백제 개발을 위한 천연 물질의 탐색이 활발히 진행되고 있다.Currently known methods for whitening include UV blocking, gene expression suppression, enzymatic activity suppression, pigment reduction and stratum corneum removal. Arbutin, kojic acid, ascorbic acid, and hydroquinone are used as representative single substances that exhibit whitening function, and the search for natural substances for the development of natural-friendly whitening agents is actively underway.
한편, 흑미(Black rice)는 단백질, 식물성 지방, 섬유소, 무기질, 비타민 등 영양 성분이 풍부하며, 항산화 활성, 동맥경화 예방 및 치료, 당뇨 예방, 면역기능증진 등에 대한 여러 가지의 효능이 보고된 바 있다. 다른 곡류에 비해 흑미의 색소성분에는 플라보노이드를 포함한 다양한 폴리페놀 화합물을 함유하고 있으며, 이는 항산화성, 항균성, 항암성 등의 생리활성을 갖는 것으로 확인되고 있다. 이러한 폴리페놀 화합물이 다량 함유된 흑미는 기능성 식품 또는 기능성 화장품 소재로 개발가능성이 있다고 예상된다.On the other hand, black rice is rich in nutrients such as protein, vegetable fat, fiber, minerals, and vitamins, and various effects on antioxidant activity, prevention and treatment of arteriosclerosis, diabetes prevention, and immune function enhancement have been reported. have. Compared to other cereals, the pigment component of black rice contains a variety of polyphenol compounds including flavonoids, which have been confirmed to have physiological activities such as antioxidant, antibacterial and anticancer properties. Black rice containing a large amount of these polyphenol compounds is expected to be developed as a functional food or functional cosmetic material.
발효는 오랜 역사를 가진 생물학 기술로, 유산균, 곰팡이, 바실러스, 효모 등의 인체에 유익한 미생물의 효소작용을 이용하여 식품 내 천연 고분자 물질을 저분자 물질로 변화시켜 체내 흡수율을 높이고, 다당체, 올리고당, 사포닌, 펩타이드, 피틴산 등의 새로운 발효산물을 얻거나 또는 상호 간의 시너지 작용에 의해 생리활성 및 기능성 효능이 상승되는 것으로 알려져 왔다. 탄수화물과 단백질을 주로 분해하는 미생물 중 하나인 곰팡이 균주는 증식하면서 분비하는 효소에 의해 생성되는 당류, 아미노산류, 유기산류 등의 맛 성분이 품질을 결정하며, 폴리페놀류 등의 유효성분이 증가함으로써 다양한 생리활성 작용을 나타낸다. 이와 같은 특징을 가지는 곰팡이류에는 아스퍼질러스 오리재(Aspergillus oryzae), 아스퍼질러스 카와치(Aspergillus kawachii), 아스퍼질러스 나이거(Aspergillus niger) 등이 있다. 그 중 아스퍼질러스 카와치는 흑국균의 백색변이주로, 탄수화물과 구연산 및 내산성 당화효소를 생산하여 입국을 제조하기가 용이하고, pH를 산성으로 변화시켜 안전하게 해주는 이점이 있다.Fermentation is a biological technology with a long history. It uses the enzyme action of microorganisms that are beneficial to the human body such as lactic acid bacteria, fungi, bacillus, yeast, etc. to increase the absorption rate in the body by converting natural high molecular substances in foods into low molecular substances, and polysaccharides, oligosaccharides and saponins. It has been known that physiological activity and functional efficacy are increased by obtaining new fermentation products such as, peptide, phytic acid, or the like or by synergistic action between them. Fungal strains, which are one of the microorganisms that mainly degrade carbohydrates and proteins, determine the quality of taste components such as sugars, amino acids, and organic acids produced by enzymes secreted while proliferating, and various physiology as active ingredients such as polyphenols increase. Shows active action. Fungi having such characteristics include Aspergillus oryzae , Aspergillus kawachii , and Aspergillus niger . Among them, Aspergillus kawachi is a white mutant of black bacterium, and it produces carbohydrates, citric acid, and acid-resistant saccharification enzyme, so it is easy to prepare the country, and it has the advantage of making it safe by changing the pH to acid.
한편, 한국등록특허 제0611428호에는 '흑미 추출물을 유효성분으로 함유하는 피부미백 화장료 조성물'이 개시되어 있고, 한국공개특허 제2005-0108541호에는 '검은콩, 흑미 및 검은깨 혼합 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물'이 개시되어 있으나, 본 발명의 항산화 활성이 증진된 발효 흑미 추출물을 유효성분으로 함유하는 피부 미백용 조성물에 대해서는 기재된 바가 없다.Meanwhile, Korean Patent No. 0611428 discloses a'skin whitening cosmetic composition containing black rice extract as an active ingredient', and Korean Patent Publication No. 2005-0108541 discloses'black bean, black rice and black sesame mixed extract as an active ingredient. A cosmetic composition for skin whitening containing as'is disclosed, but there is no description of a composition for skin whitening containing the fermented black rice extract with enhanced antioxidant activity of the present invention as an active ingredient.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 흑미 분말에 아스퍼질러스 카와치(Aspergillus kawachii)를 접종하여 발효시킨 후 열수 추출하여 발효 흑미 추출물을 제조하였고, 상기 제조된 발효 흑미 추출물이 발효되지 않은 흑미 추출물에 비해 총 폴리페놀 및 플라보노이드 함량이 증가되고 DPPH 라디칼 소거 활성이 우수할 뿐만 아니라, 티로시나아제 저해 활성이 현저하게 증가되는 것을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above requirements, and the present inventors prepared a fermented black rice extract by inoculating and fermenting black rice powder with Aspergillus kawachii , followed by hot water extraction, and the prepared fermented black rice extract Compared to the non-fermented black rice extract, the total polyphenol and flavonoid content was increased, the DPPH radical scavenging activity was excellent, and the tyrosinase inhibitory activity was significantly increased, thereby completing the present invention.
상기 과제를 해결하기 위해 본 발명은 항산화 활성이 증진된 발효 흑미 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공한다.In order to solve the above problems, the present invention provides a cosmetic composition for skin whitening comprising a fermented black rice extract with enhanced antioxidant activity as an active ingredient.
또한, 본 발명은 발효 흑미 추출물을 유효성분으로 포함하는 멜라닌 색소 과다 침착 질환의 예방 또는 개선용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for preventing or improving melanin hyperpigmentation disease comprising a fermented black rice extract as an active ingredient.
또한, 본 발명은 발효 흑미 추출물을 유효성분으로 포함하는 멜라닌 색소 과다 침착 질환의 예방 또는 치료용 약학 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for the prevention or treatment of melanin hyperpigmentation disease comprising a fermented black rice extract as an active ingredient.
또한, 본 발명은 발효 흑미 추출물을 유효성분으로 포함하는 항산화용 건강기능식품 조성물을 제공한다.In addition, the present invention provides an antioxidant health functional food composition comprising a fermented black rice extract as an active ingredient.
본 발명의 발효 흑미 추출물은 천연 유래의 물질로 인체에 안전하고 장기간 사용하여도 부작용이 없으므로, 피부 미백을 위한 기능성 화장품, 피부 색소 침착 질환을 예방 또는 개선시킬 수 있는 식품 또는 치료제로 유용하게 사용할 수 있다. The fermented black rice extract of the present invention is a natural substance that is safe for the human body and has no side effects even when used for a long period of time, so it can be usefully used as a functional cosmetic for skin whitening, a food or a therapeutic agent capable of preventing or improving skin pigmentation disorders. have.
도 1은 비발효 흑미 추출물(NF) 및 발효 흑미 추출물(F/3) 내의 총 페놀 화합물 함량을 측정한 결과이다.
도 2는 비발효 흑미 추출물(NF) 및 발효 흑미 추출물(F/3) 내의 플라보노이드 함량을 측정한 결과이다.
도 3은 비발효 흑미 추출물(NF) 및 발효 흑미 추출물(F/3)의 DPPH 라디칼 소거 활성(DPPH radical scavenging activity)을 측정한 결과이다. 양성대조군은 BHT(butylated hydroxytoluene 0.05%)를 처리한 것이다.
도 4는 비발효 흑미 추출물(NF) 및 발효 흑미 추출물(F/3)의 티로시나아제 저해 활성(tyrosinase inhibition activity)을 측정한 결과이다. 양성대조군은 Arbutin(0.05%)을 처리한 것이다.1 is a result of measuring the total phenolic compound content in non-fermented black rice extract (NF) and fermented black rice extract (F/3).
2 is a result of measuring the flavonoid content in non-fermented black rice extract (NF) and fermented black rice extract (F/3).
3 is a result of measuring the DPPH radical scavenging activity of non-fermented black rice extract (NF) and fermented black rice extract (F/3). The positive control was treated with BHT (butylated hydroxytoluene 0.05%).
4 is a result of measuring tyrosinase inhibition activity of non-fermented black rice extract (NF) and fermented black rice extract (F/3). The positive control group was treated with Arbutin (0.05%).
본 발명의 목적을 달성하기 위하여, 본 발명은 항산화 활성이 증진된 발효 흑미 추출물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a cosmetic composition for skin whitening comprising a fermented black rice extract with enhanced antioxidant activity as an active ingredient.
본 발명의 일 구현 예에 따른 피부 미백용 화장료 조성물에서, 상기 발효 흑미는 흑미 분말에 곰팡이균을 접종하여 발효한 것일 수 있고, 바람직하게는 흑미 분말에 아스퍼질러스 카와치(Aspergillus kawachii)를 접종하고 2~4일 동안, 바람직하게는 3일 동안 발효한 것일 수 있으나, 이에 제한되지 않는다.In the cosmetic composition for skin whitening according to an embodiment of the present invention, the fermented black rice may be fermented by inoculating fungal bacteria in black rice powder, preferably inoculating Aspergillus kawachii on black rice powder And it may be fermented for 2 to 4 days, preferably for 3 days, but is not limited thereto.
상기 발효 흑미 추출물은 물, 탄소수 1 내지 4의 저급 알코올 또는 이들의 혼합물을 추출용매로 이용하여 추출한 것일 수 있고, 바람직하게는 물을 추출용매로 이용하여 추출한 것일 수 있으나, 이에 제한되지 않는다.The fermented black rice extract may be extracted using water, a lower alcohol having 1 to 4 carbon atoms, or a mixture thereof as an extraction solvent, and preferably, may be extracted using water as an extraction solvent, but is not limited thereto.
본 발명에 따른 발효 흑미 추출물은 비발효 흑미 추출물에 비해 총 폴리페놀 및 플라보노이드의 함량이 높고 DPPH 라디칼 소거 활성이 우수할 뿐만 아니라 멜라닌 생성에 관여하는 티로시나아제(tyrosinase) 활성을 저해시켜, 항산화 활성 및 피부 미백 개선 효과가 우수하다.The fermented black rice extract according to the present invention has a higher content of total polyphenols and flavonoids compared to the non-fermented black rice extract and has excellent DPPH radical scavenging activity, as well as inhibiting the tyrosinase activity involved in melanogenesis, thereby inhibiting the antioxidant activity. And skin whitening improvement effect is excellent.
본 발명의 상기 피부 미백용 화장료 조성물은 스킨, 스킨 소프트너, 스킨 토너, 로션, 밀크로션, 모이스쳐로션, 영양로션, 마사지크림, 영양크림, 아이크림, 모이스쳐크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징폼, 클렌징워터, 클렌징크림, 바디로션, 바디클렌져, 비누 및 파우더 중에서 선택된 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다. The cosmetic composition for skin whitening of the present invention includes skin, skin softener, skin toner, lotion, milk lotion, moisture lotion, nutrition lotion, massage cream, nutrition cream, eye cream, moisture cream, hand cream, essence, nutrition essence, A pack, cleansing foam, cleansing water, cleansing cream, body lotion, body cleanser, soap, and powder may have any one formulation selected from, but is not limited thereto. The cosmetic composition composed of each of these formulations may contain various bases and additives necessary and appropriate for the formulation of the formulation, and the types and amounts of these components can be easily selected by those skilled in the art.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal fibers, plant fibers, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide as carrier components Etc. may be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additionally chlorofluorohydro Propellants such as carbon, propane-butane or dimethyl ether.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, a solvating agent or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene Glycol, 1,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, and the like may be used.
본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 아세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a surfactant containing cleansing, as carrier components, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, acetionate, imidazolinium derivative, methyltaurate, sarcosinate , Fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty diethanolamide, vegetable oil, linoline derivative or ethoxylated glycerol fatty acid ester, and the like may be used.
본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain excipients including fluorescent substances, fungicides, hydrophobic substances, moisturizers, fragrances, fragrance carriers, proteins, solubilizers, sugar derivatives, sunscreen agents, vitamins, plant extracts, etc. .
또한, 본 발명은 발효 흑미 추출물을 유효성분으로 포함하는 멜라닌 색소 과다 침착 질환의 예방 또는 개선용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for preventing or improving melanin hyperpigmentation disease comprising a fermented black rice extract as an active ingredient.
본 발명의 상기 건강기능식품 조성물은, 비발효 흑미 추출물에 비해 총 폴리페놀 및 플라보노이드의 함량이 높고 DPPH 라디칼 소거 활성 및 멜라닌 생성에 관여하는 티로시나아제(tyrosinase)의 저해 활성이 증가된 발효 흑미 추출물을 유효성분으로 포함하고 있어, 멜라닌 색소 과다 침착 질환에 효과가 있다.The health functional food composition of the present invention has a higher content of total polyphenols and flavonoids compared to the non-fermented black rice extract, and has increased DPPH radical scavenging activity and inhibitory activity of tyrosinase involved in melanin production. As an active ingredient, it is effective against melanin hyperpigmentation diseases.
본 발명에서 용어, '멜라닌 색소 과다 침착(hyperpigmentation)'은 피부 또는 손·발톱의 특정 부위에서 멜라닌의 과도한 증가에 의해 다른 부위에 비해 검게 또는 어둡게 되는 것을 의미한다. 상기 멜라닌 색소 과다 침착 질환은 주근깨, 노인성 반점, 간반, 기미, 갈색 또는 흑점, 일광 색소반, 푸른흑피증(cyanicmelasma), 약물 사용 후의 과다색소침착, 임신성 갈색반(gravidic chloasma), 또는 찰상 및 화상을 비롯한 상처 또는 피부염으로 인한 염증 후 과다 색소 침착인 것일 수 있으나, 이에 제한되지 않는다.In the present invention, the term "hyperpigmentation" means that a specific area of the skin or nails or nails becomes blacker or darker than other areas due to an excessive increase in melanin. The melanin hyperpigmentation disorders include freckles, senile spots, liver spots, melasma, brown or dark spots, solar pigment spots, cyanicmelasma, hyperpigmentation after drug use, gravidic chloasma, or scratches and burns. It may be hyperpigmentation after inflammation due to wounds or dermatitis including, but is not limited thereto.
상기 멜라닌 색소 과다 침착 질환의 예방 또는 개선용 건강기능식품 조성물은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다. 상기 건강기능식품 조성물은 멜라닌 색소 과다 침착 질환의 예방 또는 개선하기 위해 섭취할 수 있는 것이면 특별히 제한되지 않는다.The health functional food composition for preventing or improving the melanin hyperpigmentation disease may be prepared in any one formulation selected from powders, granules, pills, tablets, capsules, candy, syrup, effervescent tablets, and beverages, but is not limited thereto. . The health functional food composition is not particularly limited as long as it can be ingested to prevent or improve melanin hyperpigmentation disease.
본 발명의 발효 흑미 추출물을 식품첨가물로 사용하는 경우, 상기 발효 흑미 추출물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 발명의 발효 흑미 추출물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양의로 첨가된다. 그러나 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 안전성 면에서 아무런 문제가 없는 범위의 양으로 사용될 수 있다.When the fermented black rice extract of the present invention is used as a food additive, the fermented black rice extract may be added as it is or used with other foods or food ingredients, and may be appropriately used according to a conventional method. The active ingredient may be appropriately used depending on the purpose of use (prevention or improvement). In general, in the manufacture of food or beverage, the fermented black rice extract of the present invention is added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less based on the raw material. However, in the case of long-term intake for the purpose of health control, it can be used in an amount within a range without any problems in terms of safety.
상기 식품의 종류에는 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다. 상기 음료는 탄산음료, 기능성이온음료, 쥬스(예를 들어, 사과, 배,포도, 알로에, 감귤, 복숭아, 당근, 토마토쥬스 등), 식혜 등을 포함한다. There is no particular limitation on the type of food. Examples of foods to which the health functional food composition can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea There are drinks, alcoholic beverages, and vitamin complexes, and all health foods in the usual sense are included. The beverage includes carbonated beverages, functional ionic beverages, juices (eg, apples, pears, grapes, aloe, tangerines, peaches, carrots, tomato juice, etc.), sikhye, and the like.
본 발명의 기능성 식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다. 상기 건강기능식품 조성물 외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. Functional foods of the present invention include ingredients that are commonly added during food production, and include, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, when prepared as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates are monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrins, cyclodextrins, etc.) or sugar alcohols (eg , Xylitol, sorbitol, erythritol, etc.). The flavoring agent may be a natural flavoring agent (eg, taumatin, stevia extract, etc.) and a synthetic flavoring agent (eg, saccharin, aspartame, etc.). In addition to the health functional food composition, various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonic acid It may further contain a carbonation agent used in beverages.
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 저해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. 이러한 상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 조성물 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above health functional food composition, various nutrients, vitamins, inhibitors, flavoring agents, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, It may further contain a carbonating agent used in carbonated beverages. Although the ratio of the ingredients to be added is not very important, it is generally selected from 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food composition of the present invention.
또한, 본 발명은 발효 흑미 추출물을 유효성분으로 포함하는 멜라닌 색소 과다 침착 질환의 예방 또는 치료용 약학 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for the prevention or treatment of melanin hyperpigmentation disease comprising a fermented black rice extract as an active ingredient.
상기 멜라닌 색소 과다 침착 질환은 주근깨, 노인성 반점, 간반, 기미, 갈색 또는 흑점, 일광 색소반, 푸른흑피증(cyanicmelasma), 약물 사용 후의 과다색소침착, 임신성 갈색반(gravidic chloasma), 또는 찰상 및 화상을 비롯한 상처 또는 피부염으로 인한 염증 후 과다 색소 침착인 것일 수 있으나, 이에 제한되지 않는다.The melanin hyperpigmentation disorders include freckles, senile spots, liver spots, melasma, brown or dark spots, solar pigment spots, cyanicmelasma, hyperpigmentation after drug use, gravidic chloasma, or scratches and burns. It may be hyperpigmentation after inflammation due to wounds or dermatitis including, but is not limited thereto.
본 발명의 상기 약학 조성물은, 비발효 흑미 추출물에 비해 총 폴리페놀 및 플라보노이드의 함량이 높고 DPPH 라디칼 소거 활성 및 멜라닌 생성에 관여하는 티로시나아제(tyrosinase)의 저해 활성이 증가된 발효 흑미 추출물을 유효성분으로 포함하고 있어, 멜라닌 색소 과다 침착 질환에 효과가 있다.The pharmaceutical composition of the present invention is effective in fermented black rice extract with increased total polyphenol and flavonoid content compared to non-fermented black rice extract and increased DPPH radical scavenging activity and inhibitory activity of tyrosinase involved in melanogenesis. It is included as an ingredient, and is effective against melanin hyperpigmentation diseases.
본 발명의 상기 발효 흑미 추출물을 포함하는 약학 조성물은 약학적 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 또는 희석제를 더 포함할 수 있다. The pharmaceutical composition comprising the fermented black rice extract of the present invention may further include a suitable carrier, excipient, or diluent commonly used in the manufacture of pharmaceutical compositions.
본 발명의 약학 조성물의 약학적 투여 형태는 단독으로 또는 타 약학적 활성 화합물과 결합뿐만 아니라 적당한 조합으로 사용될 수 있다.The pharmaceutical dosage form of the pharmaceutical composition of the present invention may be used alone or in combination with other pharmaceutically active compounds, as well as in an appropriate combination.
본 발명에 따른 약학 조성물은, 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제제, 외용제, 좌제 및 주사제의 형태로 제형화하여 사용될 수 있다. 상기 약학 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀룰로오스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등을 포함한 다양한 화합물 혹은 혼합물을 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구 투여를 위한 고형 제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형 제제는 상기 발효물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트, 수크로오스 또는 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이 외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔, 마크로골, 트윈 61, 카카오지, 라우린지, 글리세로젤라틴 등이 사용될 수 있다.The pharmaceutical composition according to the present invention may be formulated and used in the form of oral preparations such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, etc., external preparations, suppositories, and injections according to a conventional method. . Carriers, excipients and diluents that may be included in the pharmaceutical composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, gum acacia, alginate, gelatin, calcium phosphate, calcium silicate, cellulose , Methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oils. In the case of formulation, it is prepared using diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrants, and surfactants that are usually used. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and these solid preparations contain at least one excipient, such as starch, calcium carbonate, sucrose or lactose, gelatin, etc. in the fermented product. It is prepared by mixing. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Liquid preparations for oral use include suspensions, liquid solutions, emulsions, syrups, and other excipients, such as water and liquid paraffin, which are commonly used simple diluents, such as wetting agents, sweeteners, fragrances, and preservatives. have. Preparations for parenteral administration include sterile aqueous solutions, non-aqueous solutions, suspensions, emulsions, lyophilized preparations, and suppositories. Propylene glycol, polyethylene glycol, vegetable oils such as olive oil, injectable esters such as ethyl oleate, etc. may be used as the non-aqueous solvent and suspension. As a base for suppositories, Witepsol, Macrogol, Tween 61, cacao butter, laurin paper, glycerogelatin, and the like can be used.
본 발명의 상기 약학 조성물의 바람직한 투여량은 환자의 상태 및 체중,질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 본 발명의 약학 조성물은 쥐, 생쥐, 가축, 인간 등의 포유동물에 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁 내 경막 또는 뇌혈관 내(intracerebroventricular) 주사에 의해 투여될 수 있다.The preferred dosage of the pharmaceutical composition of the present invention varies depending on the condition and weight of the patient, the degree of disease, the form of the drug, the route and duration of administration, but may be appropriately selected by those skilled in the art. The pharmaceutical composition of the present invention can be administered to mammals such as mice, mice, livestock, and humans by various routes. All modes of administration can be expected and may be administered by, for example, oral, rectal or intravenous, intramuscular, subcutaneous, intrauterine dura mater or intracerebroventricular injection.
또한, 본 발명은 발효 흑미 추출물을 유효성분으로 포함하는 항산화용 건강기능식품 조성물을 제공한다. 본 발명에 따른 발효 흑미 추출물은 비발효 흑미 추출물에 비해 총 폴리페놀 및 플라보노이드의 함량이 높고 DPPH 라디칼 소거 활성이 우수하므로, 항산화용 건강기능식품로 이용될 수 있다.In addition, the present invention provides an antioxidant health functional food composition comprising a fermented black rice extract as an active ingredient. The fermented black rice extract according to the present invention has a higher content of total polyphenols and flavonoids compared to the non-fermented black rice extract and has excellent DPPH radical scavenging activity, so it can be used as a health functional food for antioxidants.
이하, 본 발명을 실시예에 의해 상세히 설명한다 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are only illustrative of the present invention, and the contents of the present invention are not limited to the following examples.
재료 및 방법Materials and methods
1. 실험재료1. Experimental materials
흑미는 (주)오케이바이오랩에서 제공받았으며, 발효 균주는 곰팡이의 일종인 아스퍼질러스 카와치(Aspergillus kawachii) KCCM 32819 균주를 선택하여 사용하였고, YM 액체 배지(Yeast Malt broth, Difco)에서 전배양 시킨 KCCM 32819 균주(1.0×104 내지 1.0×106 CFU/mL)를 흑미 분말에 1:1 중량 비율로 접종한 후 37℃에서 3일간 발효시키고 60℃에서 8시간 동안 열풍 건조시켜 분말화하였다. Black rice was provided by OK Bio Lab Co., Ltd., and the fermentation strain was selected and used as a fungus, Aspergillus kawachii KCCM 32819 strain, and pre-cultured in YM liquid medium (Yeast Malt broth, Difco). KCCM 32819 strain (1.0 × 10 4 to 1.0×10 6 CFU/mL) was inoculated into the black rice powder at a ratio of 1:1 by weight, fermented at 37°C for 3 days, and dried with hot air at 60°C for 8 hours to powder.
2. 발효 흑미의 추출 조건2. Conditions for extraction of fermented black rice
수용성 추출물은 발효 처리되지 않은 흑미 분말 및 발효된 흑미의 건조 분말 100g에 각각 10배의 증류수를 첨가한 후 37℃에서 3시간씩 3회 환류 추출하였으며 각 추출액을 모아 Adventec 110 mm No.2 여과지(Toyo 2A; Toyo Roshi, 일본)로 여과하여 하기 실시예에 사용하였다. 실험군으로는 비발효 흑미 추출물(NF) 및 발효 흑미 추출물(F/3)로 설정하여 수행하였다. The aqueous extract was refluxed three times at 37°C for 3 hours after adding 10 times of distilled water to 100 g of unfermented black rice powder and dry powder of fermented black rice, and collected each extract with Adventec 110 mm No.2 filter paper ( Toyo 2A; Toyo Roshi, Japan) was filtered and used in the following examples. The experimental group was performed by setting the non-fermented black rice extract (NF) and the fermented black rice extract (F/3).
3. 페놀성 화합물 함량 측정3. Measurement of phenolic compound content
페놀성 화합물의 함량은 페놀성 물질이 인몰리브덴산(phosphomolybdic acid)과 반응하여 청색을 나타내는 원리를 이용한 폴린-데니스(Folin-Denis)법으로 측정하였다. 0.1%(w/v) 시료 용액 0.5㎖에 Folin-ciocalteu의 페놀 용액 2.5㎖를 첨가하여 혼합하고 5분간 실온에서 방치하였다. 정확히 5분간 반응시킨 후 7.5% 탄산나트륨(Na2CO3) 2㎖을 가하여 혼합하고 50℃에서 5분간 발색시킨 다음 분광광도계(Hitachi U-2900, Hitachi High-Technologies Co., 일본)를 이용하여 760nm에서 흡광도를 측정하였다. 이때 페놀성 화합물의 함량은 탄닌산(tannic acid)을 0~500 ㎍/㎖ 농도로 시료와 동일한 방법으로 측정하여 작성된 표준곡선으로부터 계산하였다.The content of phenolic compounds was measured by the Folin-Denis method using the principle that a phenolic substance reacts with phosphormolybdic acid to give a blue color. To 0.5 ml of a 0.1% (w/v) sample solution, 2.5 ml of a Folin-ciocalteu phenol solution was added, mixed, and allowed to stand at room temperature for 5 minutes. After reacting for exactly 5 minutes, 2 ml of 7.5% sodium carbonate (Na 2 CO 3 ) was added and mixed, followed by color development at 50°C for 5 minutes, and then 760 nm using a spectrophotometer (Hitachi U-2900, Hitachi High-Technologies Co., Japan). Absorbance was measured at. At this time, the content of phenolic compounds was calculated from a standard curve prepared by measuring tannic acid at a concentration of 0 to 500 ㎍/㎖ in the same manner as in the sample.
4. 플라보노이드 함량 측정4. Flavonoid content measurement
플라보노이드(flavonoid) 함량을 측정하기 위해 0.1%(w/v) 시료 용액 0.25 ㎖에 정제수 1.25㎖과 5% 아질산나트륨(NaNO2) 용액 5㎖을 가하고, 5분 후 10% 염화알루미늄·6수화물(AlCl3·6H2O) 0.15㎖을 혼합하고, 상기 혼합물을 분광광도계를 이용하여 510nm에서 흡광도를 측정하였다. 이때 플라보노이드 함량은 표준 물질로서 (+)-카테킨 하이드레이트(catechin hydrate)을 20~200㎍/㎖ 농도로 시료와 동일한 방법으로 측정하여 작성된 표준곡선으로부터 계산하였다.To measure the flavonoid content, 1.25 ml of purified water and 5 ml of 5% sodium nitrite (NaNO 2 ) solution were added to 0.25 ml of 0.1% (w/v) sample solution. After 5 minutes, 10% aluminum chloride hexahydrate ( 0.15 ml of AlCl 3 ·6H 2 O) was mixed, and the absorbance of the mixture was measured at 510 nm using a spectrophotometer. At this time, the flavonoid content was calculated from a standard curve prepared by measuring (+)-catechin hydrate as a standard substance at a concentration of 20 to 200 μg/ml in the same manner as the sample.
5. DPPH에 의한 항산화 활성 측정5. Measurement of antioxidant activity by DPPH
항산화 활성을 측정하기 위해 에탄올 100㎖에 DPPH(α,α'-diphenyl-β-picrylhydrazyl) 16㎎을 녹이고 증류수 100㎖을 혼합한 후 Whatman 필터지 NO. 2에 여과시켜 DPPH 반응 용액을 제조하였다. 비발효 흑미 추출물 또는 발효 흑미 추출물을 10%(w/v)의 농도로 만들어 1㎖를 취한 후 DPPH 반응 용액 5㎖을 넣어 혼합하고 암소에서 30분간 반응시킨 다음 분광광도계를 이용하여 528nm에서 흡광도를 측정하였다. 이때 활성 비교를 위하여 기존에 항산화제로 많이 사용되고 있는 합성 항산화제 BHT(butylated hydroxytoluene)를 0.05% 농도로 사용하여 시료와 동일한 방법으로 흡광도를 측정하였다. DPPH를 이용한 항산화 활성은 시료 첨가구와 무첨가구의 흡광도차를 백분율(%)로 표시하였다. DPPH 라디칼 소거능 활성(radical scavenging activity)을 구하는 식은 하기와 같다.To measure the antioxidant activity, 16 mg of DPPH (α,α'-diphenyl-β-picrylhydrazyl) was dissolved in 100 ml of ethanol, and 100 ml of distilled water was mixed. Whatman filter paper NO. Filtered through 2 to prepare a DPPH reaction solution. Make 1 ml of non-fermented black rice extract or fermented black rice extract to a concentration of 10% (w/v), add 5 ml of DPPH reaction solution, mix, react in the dark for 30 minutes, and measure the absorbance at 528 nm using a spectrophotometer. Measured. At this time, for activity comparison, absorbance was measured in the same manner as the sample using BHT (butylated hydroxytoluene), a synthetic antioxidant that has been widely used as an antioxidant, at a concentration of 0.05%. Antioxidant activity using DPPH was expressed as a percentage (%) of the difference in absorbance between the sample added and the non-added group. The equation for obtaining the DPPH radical scavenging activity is as follows.
DPPH 라디칼 소거능 활성(%)=[1-(시료 흡광도528nm)/대조구 흡광도528nm]×100DPPH radical scavenging activity (%)=[1-(sample absorbance 528nm )/control absorbance 528nm ]×100
6. 티로시나아제(6. Tyrosinase ( tyrosinasetyrosinase ) 활성 측정) Activity measurement
In vitro 머쉬룸 티로시나아제(mushroom tyrosinase) 활성 저해 활성을 측정하기 위해 1.5㎖ 플라스틱 큐벳(plastic cuvette)에 2.5mM L-DOPA(3,4-dihydroxyphenylalanine) 0.3㎖, 1%(w/v) 농도의 비발효 흑미 추출물 또는 발효 흑미 추출물 0.05㎖ 및 0.1M 인산완충용액(pH 6.8)을 혼합하여 25℃에서 반응시킨 후 1,380 units/㎖ 머쉬룸 티로시나아제(2,500 unit, Sigma Chemical Co., St. 미국) 0.05㎖을 넣고 25℃에서 2분간 반응시키면서 분광광도계를 이용하여 470nm에서 흡광도를 측정하여 계산하였다. 대조구는 시료가 들어있지 않는 시료 용해 용액을 사용하였고, 양성대조구는 티로시나아제 저해제로 알려진 0.05% 알부틴(Arbutin)을 사용하였다. 티로시나아제 저해 활성을 구하는 식은 하기와 같다.To measure the in vitro mushroom tyrosinase activity inhibitory activity, 2.5mM L-DOPA (3,4-dihydroxyphenylalanine) 0.3ml, 1% (w/v) concentration in 1.5ml plastic cuvette. After mixing 0.05 ml of non-fermented black rice extract or fermented black rice extract and 0.1 M phosphate buffer solution (pH 6.8) and reacting at 25°C, 1,380 units/ml mushroom tyrosinase (2,500 units, Sigma Chemical Co., St. USA) 0.05 ml was added and the absorbance was measured and calculated at 470 nm using a spectrophotometer while reacting at 25° C. for 2 minutes. A sample dissolution solution containing no sample was used as a control, and 0.05% arbutin, known as a tyrosinase inhibitor, was used as a positive control. The formula for obtaining the tyrosinase inhibitory activity is as follows.
Tyrosinase 활성 저해율(%)=100-[(A-B)/A] X 100Tyrosinase activity inhibition rate (%)=100-[(A-B)/A]
(A; 시료가 들어있지 않은 반응액의 0.5~1분 사이의 흡광도 차이, B; 시료가 들어있는 반응액의 0.5~1분 사이의 흡광도 차이)(A; difference in absorbance between 0.5 and 1 minute of the reaction solution without sample, B; difference in absorbance between 0.5 and 1 minute of the reaction solution containing sample)
7. 통계처리7. Statistical processing
상기 실험으로부터 얻어진 결과는 one-way ANOVA 검정에 의한 평균치와 표준편차(mean± SE)로 표시하였고, 각 실험 군 간의 유의성 검증은 Duncan's multiple range test로 나타내었다.The results obtained from the above experiment were expressed as the mean value and standard deviation (mean±SE) by the one-way ANOVA test, and the verification of significance between each experimental group was indicated by Duncan's multiple range test.
실시예Example 1. 발효 흑미 추출물의 총 폴리페놀 및 플라보노이드 함량 분석 1. Analysis of Total Polyphenol and Flavonoid Contents of Fermented Black Rice Extract
폴리페놀 화합물은 식물계에 널리 분포되어 있는 2차 대사산물로 플라보노이드(flavonoid), 카테킨(catechin), 탄닌(tannin)으로 크게 구분된다. 특히, 페놀성 화합물들은 전자공여능이 있어 높은 항산화 작용을 나타내는 것으로 알려져 있다. Polyphenol compounds are secondary metabolites that are widely distributed in the plant world and are largely classified into flavonoids, catechins, and tannins. In particular, phenolic compounds are known to exhibit high antioxidant activity due to their electron donating ability.
비발효 흑미 추출물과 발효 흑미 추출물의 총 폴리페놀 및 플라보노이드 함량을 측정한 결과, 총 폴리페놀 함량은 비발효 흑미 추출물 처리군(NF)에서 14.59mg/100g, 발효 흑미 추출물 처리군(F/3)에서 42.28mg/100g이었고(도 1), 플라보노이드 함량은 NF군에서 18.23mg/100g, F/3군에서 50.67mg/100g임을 확인하였다(도 2). 즉, 비발효 흑미 추출물에 비해 발효 흑미 추출물에서 총 폴리페놀 함량 및 플라보노이드 함량이 증가하였다. As a result of measuring the total polyphenol and flavonoid contents of the non-fermented black rice extract and the fermented black rice extract, the total polyphenol content was 14.59 mg/100 g in the non-fermented black rice extract treatment group (NF), and the fermented black rice extract treatment group (F/3). Was 42.28mg/100g (Fig. 1), and the flavonoid content was 18.23mg/100g in the NF group and 50.67mg/100g in the F/3 group (FIG. 2). That is, total polyphenol content and flavonoid content were increased in fermented black rice extract compared to non-fermented black rice extract.
실시예Example 2. 발효 흑미 추출물의 2. Fermented Black Rice Extract DPPHDPPH 라디칼Radical 소거 활성 분석 Scavenging activity assay
비발효 흑미 추출물 및 발효 흑미 추출물의 DPPH 라디칼 소거 활성을 측정하였고, 양성대조군에는 시중에서 판매하고 있는 합성 항산화제인 BHT 0.05%를 처리하였다. 그 결과, DPPH 라디칼 소거 활성이 비발효 흑미 추출물 처리군(NF)에서 17.5%이고, 발효 흑미 추출물 처리군(F/3)에서 53.33%로 DPPH 라디칼 소거활성이 크게 증가하였다(도 3).The DPPH radical scavenging activity of the non-fermented black rice extract and the fermented black rice extract was measured, and the positive control group was treated with 0.05% of BHT, a commercially available synthetic antioxidant. As a result, DPPH radical scavenging activity was 17.5% in the non-fermented black rice extract treatment group (NF), and the DPPH radical scavenging activity was significantly increased to 53.33% in the fermented black rice extract treatment group (F/3) (FIG. 3).
실시예Example 3. 발효 흑미 추출물의 티로시나아제 저해 활성 분석 3. Analysis of Tyrosinase Inhibitory Activity of Fermented Black Rice Extract
멜라닌(melanin)은 피부, 머리카락, 눈동자 등 인간을 비롯한 생물체에 널리 분포되어 있는 색소 성분으로 인체에서는 표피층의 멜라닌 세포(melanocyte) 내의 멜라노솜(melanosome)에서 합성되는데, 아미노산의 일종인 티로신(tyrosine)을 시발물질로 하여 티로시나아제(tyrosinase) 효소에 의해 DOPA(3,4-dihydroxy-phenylalanine) 또는 DOPA 퀴논(quinone)으로 산화된 후 비효소적 반응과 자동 산화 과정을 거쳐 단백질 또는 그 구성 아미노산과 중합 반응을 통해 멜라닌이 합성된다. 이때 생성된 멜라닌은 피부의 색을 검게하므로 티로시나아제의 활성을 효과적으로 저해하는 실험이 미백효과를 확인하는 매우 유용한 연구방법으로 평가받고 있다. 양성대조군에는 시중에서 판매하고 있는 알부틴(Arbutin) 0.05%를 처리하였다.Melanin is a pigment component that is widely distributed in living organisms including humans such as skin, hair, and eyes. In the human body, it is synthesized from melanosomes in melanocytes in the epidermis, and is a kind of amino acid, tyrosine. As a starting material, it is oxidized to DOPA (3,4-dihydroxy-phenylalanine) or DOPA quinone by tyrosinase enzyme, followed by a non-enzymatic reaction and an automatic oxidation process. Melanin is synthesized through polymerization. Since the melanin produced at this time darkens the color of the skin, an experiment that effectively inhibits the activity of tyrosinase is evaluated as a very useful research method to confirm the whitening effect. In the positive control group, 0.05% of commercially available arbutin was treated.
비발효 흑미 추출물 및 발효 흑미 추출물의 티로시나아제 저해 활성을 측정한 결과, 도 4에 개시한 바와 같이 비발효 흑미 추출물 처리군(NF)에서 티로시나아제 저해 활성이 전혀 나타나지 않았으나, 발효 흑미 추출물 처리군(F/3)에서 약 21%로 현저하게 증가하였고 이는 흑미와 발효에 사용된 곰팡이균인 아스퍼질러스 카와치(Aspergillus kawachii)의 시너지 상승효과로, 미백 활성의 유효성분이 유리되어 나타나는 것으로 사료되었다.As a result of measuring the tyrosinase inhibitory activity of the non-fermented black rice extract and the fermented black rice extract, as disclosed in FIG. 4, no tyrosinase inhibitory activity was observed in the non-fermented black rice extract treatment group (NF), but the fermented black rice extract treatment In group (F/3), it was remarkably increased to about 21%, which is a synergistic synergistic effect of Aspergillus kawachii , a fungus used for black rice and fermentation, and it is believed that the active ingredient of whitening activity is released . Became.
Claims (7)
음료 중에서 선택된 어느 하나의 제형으로 제조되는 것을 특징으로 하는 멜라닌 색소 과다 침착 질환의 예방 또는 개선용 건강기능식품 조성물.The method of claim 3, wherein the composition is powder, granule, pill, tablet, capsule, candy, syrup and
A health functional food composition for preventing or improving melanin hyperpigmentation disease, characterized in that it is prepared in any one formulation selected from beverages.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190095822A KR102239470B1 (en) | 2019-08-07 | 2019-08-07 | Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190095822A KR102239470B1 (en) | 2019-08-07 | 2019-08-07 | Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210017108A true KR20210017108A (en) | 2021-02-17 |
KR102239470B1 KR102239470B1 (en) | 2021-04-12 |
Family
ID=74732331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190095822A KR102239470B1 (en) | 2019-08-07 | 2019-08-07 | Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102239470B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050075516A (en) * | 2004-01-15 | 2005-07-21 | 주식회사 코리아나화장품 | Cosmetic composition comprising oryza sativa l. extracts |
KR101532003B1 (en) * | 2014-10-29 | 2015-06-26 | 재단법인 금산국제인삼약초연구소 | Cosmetics comprising fermented materials for skin antioxidant |
KR101637396B1 (en) * | 2015-08-12 | 2016-07-07 | 주식회사 단정바이오 | Cosmetic composition for improving anti-oxidation, anti-inflammatory and atopic skin and method of preparing the same |
KR101737940B1 (en) * | 2010-11-19 | 2017-05-22 | (주)아모레퍼시픽 | Composition of skin external application containing fermented soybean leaves extract |
KR101773081B1 (en) * | 2015-12-31 | 2017-08-30 | 국가식품클러스터지원센터 | Dolwoe fermented extracts comprising saponins as an active functional food ingredient and preparation method thereof |
KR20190061544A (en) * | 2017-11-28 | 2019-06-05 | 지에스피주식회사 | Cosmetic Composition for Anti-oxidation and Whitening comprising fermented silkworm extract as effective component |
-
2019
- 2019-08-07 KR KR1020190095822A patent/KR102239470B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050075516A (en) * | 2004-01-15 | 2005-07-21 | 주식회사 코리아나화장품 | Cosmetic composition comprising oryza sativa l. extracts |
KR101737940B1 (en) * | 2010-11-19 | 2017-05-22 | (주)아모레퍼시픽 | Composition of skin external application containing fermented soybean leaves extract |
KR101532003B1 (en) * | 2014-10-29 | 2015-06-26 | 재단법인 금산국제인삼약초연구소 | Cosmetics comprising fermented materials for skin antioxidant |
KR101637396B1 (en) * | 2015-08-12 | 2016-07-07 | 주식회사 단정바이오 | Cosmetic composition for improving anti-oxidation, anti-inflammatory and atopic skin and method of preparing the same |
KR101773081B1 (en) * | 2015-12-31 | 2017-08-30 | 국가식품클러스터지원센터 | Dolwoe fermented extracts comprising saponins as an active functional food ingredient and preparation method thereof |
KR20190061544A (en) * | 2017-11-28 | 2019-06-05 | 지에스피주식회사 | Cosmetic Composition for Anti-oxidation and Whitening comprising fermented silkworm extract as effective component |
Non-Patent Citations (1)
Title |
---|
쿼럼바이오, 흑미 발효 추출물 화장품 ‘루비앰플’ 킥스타터 출격, 비즈니스 코리아, 정민희 기자 (2019.07.16.)* * |
Also Published As
Publication number | Publication date |
---|---|
KR102239470B1 (en) | 2021-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101513237B1 (en) | Cosmetic composition containing verbenone from rosemary for improving skin whitening as an effective component | |
EP3854379A1 (en) | Cosmetic composition comprising centella asiatica adventitious root extract as effective ingredient for skin whitening and wrinkle reduction | |
KR20170132388A (en) | Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata | |
KR102149177B1 (en) | Vinegar with enhanced skin whitening effect using Aster scaber and Ficus carica and production method thereof | |
EP2123290A1 (en) | Melanogenesis inhibitory composition | |
KR102442861B1 (en) | Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing Pediococcus acidilactici PMC48 strain a culture medium thereof as an active ingredient | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR101453258B1 (en) | Health Functional Food Composition Comprising Red Ginseng Extract, Benincasa Hispida Extract, and Apios Americana Extract for Improving Skin Beauty | |
KR102053994B1 (en) | Cosmetic composition for skin whitening and moisturizing comprising larva extract of Protaetia brevitarsis as effective component | |
KR101863895B1 (en) | Composition for skin whitening comprising Stachys sieboldii extract fermented using Hericium erinaceum mycelium as effective component | |
KR102239470B1 (en) | Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component | |
KR102159607B1 (en) | Composition for skin whitening or anti-inflammatory comprising extract of fermented Angelica gigas with improved antioxidant activity as effective component | |
KR102370528B1 (en) | Compositions containing Beta vulgaris fermentation extract | |
KR102320424B1 (en) | Cosmetic composition for anti-wrinkle and whitening comprising Lilium longiflorum extract and Allium hookeri extract as active ingredients | |
KR101551106B1 (en) | A composition comprising the extract of Paspalum thunbergii Kunth | |
KR20140117168A (en) | Composition containing enzymated thanakha extract | |
KR101995384B1 (en) | Composition for skin whitening and anti-oxidation comprising fermented Gynura procumbens as effective component | |
KR102128168B1 (en) | Composition comprising the extract of Lentinula edodes and Acer pictum subsp. mono leaf for antioxidant effect | |
KR102058022B1 (en) | Composition for antioxidant and anti-inflammatory comprising fraction of Ledum palustre L. extract as effective component | |
KR101761142B1 (en) | Skin-lightening Composition Using an Extract of Rumex acetosella | |
KR102539089B1 (en) | Composition for skin whitening and anti-oxidant comprising fermented product of Angelica dahurica extract as effective component | |
JP4902967B2 (en) | Melanin production inhibitor | |
KR102355138B1 (en) | Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component | |
KR102515649B1 (en) | Cosmetic composition for skin whitening and anti-wrinkle comprising extract of steamed Polygonatum sibiricum as effective componenet | |
KR102525129B1 (en) | Composition comprising fermented extracts of unripe plum and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |